US Patent 8129591 Polypeptides having xylanase activity and polynucleotides encoding same
Patent 8129591 was granted and assigned to Novozymes on March, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+320 characters)
Article
Patent abstract
The present invention relates to isolated polypeptides having xylanase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Eric Abbate0
Kimberly Brown0
Michelle Maranta0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08129591 Polypeptides having xylanase activity and polynucleotides encoding same US Patent 8129591 Polypeptides having xylanase activity and polynucleotides encoding same
Infobox
Patent Number
081295910
Patent Number
81295910
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
081295910
Date of Patent
March 6, 2012
0Patent Application Number
127653580
Date Filed
April 22, 2010
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08129591 Polypeptides having xylanase activity and polynucleotides encoding same
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08129591
Date of patent
March 6, 2012
Patent application number
12765358
Date Filed
April 22, 2010
Patent primary examiner
Find more entities like US Patent 8129591 Polypeptides having xylanase activity and polynucleotides encoding same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
